IMMUNODEFICIENCY
Clinical trials for IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for vulnerable patients: can stronger antiviral cocktails beat COVID-19?
Disease control Recruiting nowThis study looks at whether using two antiviral drugs together (remdesivir plus nirmatrelvir/r) works better than one drug alone for treating COVID-19 in people with weakened immune systems. It also tests if taking the medication for 10 days instead of 5 helps clear the virus fas…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: Calmy Alexandra • Aim: Disease control
Last updated May 17, 2026 05:27 UTC
-
New hope for vulnerable patients: shorter, stronger COVID-19 treatment on trial
Disease control Recruiting nowThis study looks at whether giving a combination of two antiviral drugs or a longer treatment course can help people with weakened immune systems clear COVID-19 faster. About 256 participants with mild or no symptoms will receive either standard treatment or an enhanced approach.…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a stem cell transplant tame VEXAS? new trial aims to find out
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can control VEXAS syndrome, a rare and severe autoinflammatory disease. Up to 54 adults aged 18-75 who have not responded to standard treatments will receive donor stem cells after chemotherapy and possibly radi…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a donor stem cell transplant can help prevent serious viral and fungal infections. It involves up to 100 children and young adults with blood cancers or immune disorders. The approach aims to spe…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Stem cell transplant offers hope for rare genetic blood disease
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can treat GATA2 deficiency, a genetic condition that weakens the immune system and raises the risk of leukemia. Participants aged 6 to 70 receive chemotherapy or radiation before the transplant to prepare their …
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Scientists hunt for genes behind immune disorders
Knowledge-focused Recruiting nowThis study looks for genes that cause certain immune system problems. It includes up to 5,000 people with known or suspected genetic immune disorders and their family members. Researchers collect blood, cheek swabs, or skin samples to find genetic changes and learn how these cond…
Matched conditions: IMMUNODEFICIENCY
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Parkinson's drug may hide immune danger: new study investigates
Knowledge-focused Recruiting nowThis study looks at whether clozapine, a drug used to treat psychosis in Parkinson's disease, can weaken the immune system over time. Researchers will measure immune cells and antibodies in 24 patients before and after 6 months and 1 year of treatment. The goal is to understand i…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC